Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Organogenesis Holdings Inc.

ORGO · Nasdaq · CIK 0001661181 · Healthcare · Drug Manufacturers—Specialty & Generic

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

0 Form 4 transaction lines observed in the same window
0 sales · 0 option, withholding, award, gift or other lines

Last qualifying purchase2026-03-09 · Leibowitz Arthur S · $13.4K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesNone
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

No Form 4 transaction event is present in the current 180-day window.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-03-09 · Leibowitz Arthur S.

Recent Form 4 activity

2Purchases
4Sales
70Other Form 4 lines
33SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER0 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
15,002,130
Previous report
14,119,761
Avg daily volume
563,439
Days to cover
26.6

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-03-09Leibowitz Arthur SPurchase (P)Class A Common Stock5,000USD 2.68USD 13,400SEC filing ↗
2026-03-09Driscoll Michael JosephPurchase (P)Class A Common Stock10,000USD 2.67USD 26,700SEC filing ↗
2025-06-06Freedman LoriPurchase (P)Class A Common Stock9,022USD 2.99USD 26,976SEC filing ↗
2025-06-05Freedman LoriPurchase (P)Class A Common Stock142,379USD 2.91USD 414,323SEC filing ↗
2025-06-04Freedman LoriPurchase (P)Class A Common Stock100,863USD 2.82USD 284,434SEC filing ↗
2025-05-15NUSSDORF GLENN HPurchase (P)Class A Common Stock107,494USD 2.99USD 321,407SEC filing ↗
2025-05-14NUSSDORF GLENN HPurchase (P)Class A Common Stock251,001USD 3.09USD 775,593SEC filing ↗
2022-11-21KATZ MICHAEL WPurchase (P)Class A Common Stock3,000USD 2.56USD 7,680SEC filing ↗
2022-11-18KATZ MICHAEL WPurchase (P)Class A Common Stock3,000USD 2.57USD 7,710SEC filing ↗
2022-08-12Leibowitz Arthur SPurchase (P)Class A Common Stock3,000USD 4.76USD 14,280SEC filing ↗
2022-08-12Driscoll Michael JosephPurchase (P)Class A Common Stock5,000USD 4.80USD 24,000SEC filing ↗
2022-05-16KATZ MICHAEL WPurchase (P)Class A Common Stock10,000USD 6.03USD 60,320SEC filing ↗
2021-12-13KATZ MICHAEL WPurchase (P)Class A Common Stock500USD 9.65USD 4,825SEC filing ↗
2021-12-03KATZ MICHAEL WPurchase (P)Class A Common Stock800USD 9.35USD 7,480SEC filing ↗
2021-12-02KATZ MICHAEL WPurchase (P)Class A Common Stock1,800USD 9.66USD 17,390SEC filing ↗

Form 4 evidence

76 transaction lines in the latest 365-day window; 433 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-03-09Leibowitz Arthur SPurchase (P)Class A Common Stock5,000USD 2.68USD 13,400SEC filing ↗
2026-03-09Driscoll Michael JosephPurchase (P)Class A Common Stock10,000USD 2.67USD 26,700SEC filing ↗
2026-03-01Cavorsi RobertTax withholding (F)Class A Common Stock700USD 3.21USD 2,247SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-03-09Leibowitz Arthur SPurchase (P)Class A Common Stock5,000USD 2.68USD 13,400SEC filing ↗
2026-03-09Driscoll Michael JosephPurchase (P)Class A Common Stock10,000USD 2.67USD 26,700SEC filing ↗
2026-03-01Cavorsi RobertTax withholding (F)Class A Common Stock700USD 3.21USD 2,247SEC filing ↗
2026-02-18Montecalvo Antonio S.Tax withholding (F)Class A Common Stock3,778USD 3.84USD 14,508SEC filing ↗
2026-02-18Montecalvo Antonio S.Award / grant (A)Class A Common Stock11,330USD 0.00USD 0SEC filing ↗
2026-02-18Grow BrianTax withholding (F)Class A Common Stock11,887USD 3.84USD 45,646SEC filing ↗
2026-02-18Grow BrianAward / grant (A)Class A Common Stock48,818USD 0.00USD 0SEC filing ↗
2026-02-18Gillheeney Gary S.Tax withholding (F)Class A Common Stock91,311USD 3.84USD 350,634SEC filing ↗
2026-02-18Gillheeney Gary S.Award / grant (A)Class A Common Stock188,856USD 0.00USD 0SEC filing ↗
2026-02-18Freedman LoriTax withholding (F)Class A Common Stock14,411USD 3.84USD 55,338SEC filing ↗
2026-02-18Freedman LoriAward / grant (A)Class A Common Stock43,212USD 0.00USD 0SEC filing ↗
2026-02-18Francisco DavidTax withholding (F)Class A Common Stock14,687USD 3.84USD 56,398SEC filing ↗
2026-02-18Francisco DavidAward / grant (A)Class A Common Stock44,040USD 0.00USD 0SEC filing ↗
2026-02-18Cavorsi RobertTax withholding (F)Class A Common Stock5,487USD 3.84USD 21,070SEC filing ↗
2026-02-18Cavorsi RobertAward / grant (A)Class A Common Stock16,454USD 0.00USD 0SEC filing ↗
2026-02-18Bilbo PatrickTax withholding (F)Class A Common Stock16,375USD 3.84USD 62,880SEC filing ↗
2026-02-18Bilbo PatrickAward / grant (A)Class A Common Stock49,102USD 0.00USD 0SEC filing ↗
2026-02-18Quintero GilbertoAward / grant (A)Class A Common Stock48,828USD 0.00USD 0SEC filing ↗
2026-02-18Montecalvo Antonio S.Tax withholding (F)Class A Common Stock3,741USD 3.84USD 14,365SEC filing ↗
2026-02-18Montecalvo Antonio S.Award / grant (A)Class A Common Stock51,843USD 0.00USD 0SEC filing ↗
2026-02-18Lustig GarrettAward / grant (A)Class A Common Stock48,828USD 0.00USD 0SEC filing ↗
2026-02-18Leibowitz Arthur SAward / grant (A)Class A Common Stock48,828USD 0.00USD 0SEC filing ↗
2026-02-18Korfin Michele IleneAward / grant (A)Class A Common Stock48,828USD 0.00USD 0SEC filing ↗
2026-02-18Grow BrianTax withholding (F)Class A Common Stock11,768USD 3.84USD 45,189SEC filing ↗
2026-02-18Grow BrianAward / grant (A)Class A Common Stock282,705USD 0.00USD 0SEC filing ↗
2026-02-18Gillheeney Gary S.Tax withholding (F)Class A Common Stock90,398USD 3.84USD 347,128SEC filing ↗
2026-02-18Gillheeney Gary S.Award / grant (A)Class A Common Stock1,077,593USD 0.00USD 0SEC filing ↗
2026-02-18Giacomin Jon LAward / grant (A)Class A Common Stock48,828USD 0.00USD 0SEC filing ↗
2026-02-18Freedman LoriTax withholding (F)Class A Common Stock14,267USD 3.84USD 54,785SEC filing ↗
2026-02-18Freedman LoriAward / grant (A)Class A Common Stock245,905USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerORGO
CIK0001661181
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history433 transaction lines from 2020-01-21 to 2026-03-09
46 P purchase lines · 83 S sale lines · 304 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.